title: Pharmacological treatment of gallstones. Practical guidelines.
abstract: Laparoscopic cholecystectomy is the treatment of choice for symptomatic cholelithiasis. Medical treatment is indicated for patients who are not fit or are afraid of surgery. For any form of medical treatment to be effective gallstones must be cholesterol rich, thus radiolucent, and the cystic duct must be patent, as indicated by gallbladder opacification on oral cholecystography. Three forms of medical treatment are currently available for clinical use--oral bile acids, bile acids as adjuncts to lithotripsy and contact dissolution using methyltertbutylether. The choice of treatment depends mainly on gallstone size. Gallstones < 6 mm in diameter are best treated with oral bile acids, chenodeoxycholic acid 15 mg/kg/day or ursodeoxycholic acid 10 mg/kg/day given alone or in combination (5 mg/kg/day each). Careful patient selection and bedtime administration of the whole daily bile acid dose enhance treatment, and may achieve up to 75% complete dissolution annually. Single stones < 30 mm in diameter or multiple stones (n < 3) are best treated with lithotripsy combined with oral bile acid for dissolution of fragments. Annual dissolution rates are about 80 and 40% for single and multiple stones, respectively. Stones of any size and number can be dissolved by direct contact dissolution using methyltertbutylether. Dissolution has been reported to be complete in almost 100% of stones, but debris is frequently left behind in the gallbladder. Following dissolution using any form of treatment, gallstones recur in about 50% of patients, and cannot be reliably prevented by low dose bile acid or dietary manipulations. Failing prevention, early detection and retreatment of recurrent stones is the best alternative option as a long term strategy.
authors.affiliation: Department of Clinical Medicine, University of Brescia, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Lanzini
authors.forename: T C
authors.initials: TC
authors.lastname: Northfield
mesh_terms: D000465:Algorithms; D001647:Bile Acids and Salts / Q000009:adverse effects / Q000627:therapeutic use*; D002763:Cholecystectomy; D002769:Cholelithiasis / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008096:Lithotripsy; D012008:Recurrence
chemical_list: D001647:Bile Acids and Salts